Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Aug 18.
Published in final edited form as: Nurs Res. 2007;56(5):296–306. doi: 10.1097/01.NNR.0000289502.45284.b5

Ethnic Differences in Cancer Pain Experience

Eun-ok Im
PMCID: PMC2728600  NIHMSID: NIHMS58781  PMID: 17846550

Abstract

Background

Inconsistent findings on ethnic differences in cancer pain experience suggest the need for further studies on this topic for adequate cancer pain management.

Objectives

The purpose of this study was to determine ethnic differences in cancer pain experience of 4 ethnic groups in the U.S.

Methods

A feminist perspective provided the theoretical basis. This was a survey of a multiethnic sample of 480 cancer patients asking questions on sociodemographic characteristics and health/illness status, 3 unidimensional cancer pain scales, 2 multidimensional cancer pain scales, the Memorial Symptom Assessment Scale, and the Functional Assessment of Cancer Therapy Scale. The data were analyzed using descriptive and inferential statistics including ANOVA and hierarchical multiple regression analyses.

Results

The results indicated certain ethnic differences in types of pain and symptoms that patients experienced. Also, the results demonstrated significant ethnic differences in cancer pain and functional status. The VDS, VAS, FS, MPQ, and BPI scores of Non-Hispanic (N-H) Asian participants were significantly lower than those of Hispanic and N-H White participants (p<.01). The VAS and MPQ scores of N-H African American participants were significantly lower than those of Hispanic and N-H White participants (p<.01). The FACT-G scores of N-H Asian participants were significantly lower than Hispanic participants (p<.01). The findings also indicated that being N-H Asian or not was a significant predictor of the VDS, FS, and BPI scores.

Discussion

The findings suggest further in-depth qualitative exploration on cultural values and beliefs related to cancer pain in each ethnic group and national-scope studies with a larger number of ethnic minorities on this topic.


Ethnicity is a sociocultural contextual factor influencing persons’ pain expression and experience that has recently been recognized, and a few researchers have begun to report ethnic variations in cancer pain experience (Laliberte, 2003; Miaskowski, 2004). In a national study, Cleeland et al. (1994) reported that, in settings with predominantly ethnic minority patients including Hispanics and African Americans, 62% of those patients were undertreated according to the World Health Organization (WHO) standards, and they were three times more likely to be undermedicated than patients seen in non-minority settings with predominantly White cancer patients. In another study by Cleeland et al. (1997), researchers reported that 74% of Hispanics and 59% of African American patients with pain did not receive the WHO-recommended analgesics for their pain. In a subsequent study, Anderson et al. (2000) reported that 28% of Hispanic and 31% of African American patients received analgesics that were insufficient to manage their pain.

Despite these findings, some recent studies indicated no such variation in pain experience by ethnicity: no ethnic differences in cancer pain experience, measures of pain sensation, pain ratings of ethnically diverse groups of men with myocardial infarction, pain ratings during childbirth, and behavior responses and pain ratings of children with cancer (Edrington et al., 2004; Rustøen, Fosså, Skarstein, & Moum, 2003; Rabow & Dibble, 2005). As these inconsistent findings indicate, it would be hasty to conclude that there are or are not ethnic differences in cancer pain experience, so further studies are needed to develop reliable knowledge that can be used to more adequately manage the pain of cancer patients. Furthermore, existing studies tend to include only a limited number of ethnic minorities, and very few national scope studies having an adequate number of ethnic minorities for valid comparisons have been conducted.

The purpose of the study reported in this paper was to determine ethnic differences in reported cancer pain experiences among four of the most common ethnic groups in the U.S. (Hispanic, non-Hispanic (N-H) White, N-H African-American, and N-H Asian). Cancer patients have been reported to experience pain with diverse symptoms, impairments in physical and psychological functioning, and other difficulties that can undermine their quality of life across all states and times (Dodd, 2001). Significant positive relationships between cancer pain intensity and psychological and physical symptoms have been reported (Poulos, Gertz, Pankratz, & Post-White, 2001). Thus, in this study, cancer pain was defined as a multidimensional subjective experience, which accompanies symptoms and changes in functional status. To achieve the purpose, it was hypothesized that there are significant differences in self-reported cancer pain, symptoms accompanying pain, and functional status according to self-reported ethnic identity (Hypothesis 1). Then, to determine the effects of ethnicity on cancer pain, symptoms, and functional status while considering the effects of other demographic and health/illness factors, it was hypothesized that ethnicity adds significantly to the prediction of the cancer pain, symptom, and functional status scores after controlling for selected demographic and health/illness factors (Hypothesis 2).

The study reported in this paper relies on a theoretical grounding in feminist perspectives. It was assumed that the inadequate assessment of cancer pain reported by patients does not only come from pure biology, but from their continuous interactions with their environment (Hall & Stevens, 1991). For example, an ethnic minority cancer patient who may have particular difficulty feeling in control in a setting dominated by well-educated professionals may fail to clearly express her/his needs and fail to demand that her/his need for pain control be met (Ramer et al., 1999). In this case, inadequate management of cancer pain could be claimed to result from cancer patients’ interactions with their environments. In the study reported in this paper, using a feminist perspective, patients’ own views and experiences were respected, and ethnicity was viewed as a significant characteristic that influences cancer patients’ interactions with their environments and structures the cancer pain assessment and management processes.

Methods

This was a cross-sectional comparative survey design of a multiethnic sample of 480 cancer patients in the U.S., which was a part of a larger study that aimed at development of a decision support system for cancer pain management. More findings from the larger study can be found elsewhere (Authors, 2006).

Sample and Settings

A total of 480 cancer patients were recruited through both Internet and community settings. To test the differences in cancer pain, symptoms accompanying pain, and functional status according to the four ethnic groups (Hypothesis 1), we assumed a conventional effect size of .20 (Cohen, 1988). With alpha = 0.05, 68 participants per ethnic group would be needed to detect a statistically significant difference with power greater than 0.80 (Cohen, 1988). The reason for setting power at .80 was that a power level of .80 is adequate for most studies (Murphy & Myors, 2004), and higher levels of power (e.g., .90 and .95) are difficult to achieve and require muc larger sample sizes to detect even a small effect size of .20. According to Tabachnick and Fidell (2001), a rule of thumb for conducting multiple regression (Hypothesis 2) is to have N >= 104 + m, where N=sample size and m=number of independent variables. Since the number of independent variables that were included in the multiple regression analyses was 10 (4 independent variables tested including dummy variables + 6 independent variables controlled), the sample size needed for the multiple regression analyses was lager than 111 (104+10=124). Since 480 (105 Hispanics, 148 N-H Whites, 109 N-H African Americans, and 118 Asians) cancer patients were recruited, the sample size was enough to test Hypotheses 1 and 2.

Among 480 cancer patients, 204 were recruited through Internet settings, and 276 were recruited through community settings. The Internet settings for recruitment were Internet cancer support groups (ICSGs) identified through Google, MSN, and Yahoo searches. The community settings were cancer clinics and cancer support groups across the U.S. that were also identified by Internet searches. Ten community consultants who were formal or informal leaders of the community clinics and support groups that were identified through the Internet searches and who had direct contacts with ethnic minority cancer patients in the community settings (2 Hispanic, 4 Asian, and 4 African American community consultants) helped the recruitment process. During the recruitment process, if the community consultants requested hard copies of the questionnaires (pen-and-pencil questionnaires), hard copies were provided to potential participants through the community consultants. Participants recruited through the community consultants included both those who filled out the questionnaires through the Internet (30 cancer patients) and those who filled out hard copies (246 cancer patients).

The inclusion criteria for research participants were: cancer patients aged at least 18 years who could read and write English and whose self-reported ethnic identity was Hispanic, non-Hispanic (N-H) White, N-H African American, or N-H Asian. Since the use of multiple languages was impossible due to the inherent diversity and complexities within ethnic groups, only English was used throughout the research process. Thus, only those who could read and write English were recruited.

Sociodemographic characteristics of the participants are summarized in Table 1. The participants included 105 Hispanics, 148 N-H Whites, 109 N-H African Americans, and 118 Asians. About 79% of the participants were women, and about 20% were men. Although a gender-balanced sample was the aim, using multiple recruitment strategies including direct and indirect contacts through both Internet and community settings, women were inadvertently over-sampled. One possible reasons might be that women outnumber men in the cancer population (American Cancer Society, 2006) and in the Internet population (Fallows, 2005).

Table 1.

Sociodemographic characteristics of the participants (N=480)

Characteristics N (%) Characteristics N (%)
Age Gender
 Mean (SD) 51.92 (12.27)  Women 381 (79.4)
 Men 97 (20.2)
Ethnicity Employment
 Hispanic 105 (21.9)  Employed 190 (39.6)
 N-H White 148 (30.8)  Unemployed 290 (60.4)
 N-H African American 109 (22.7)
 N-H Asian 118 (24.6)
Education Religion
 No school 4 (0.8)  Muslim 1 (0.2)
 Elementary 23 (4.8)  Buddhist 35 (7.3)
 Middle-school 29 (6.0)  Catholic 120 (25.0)
 High-school 127 (26.5)  Protestant 114 (23.8)
 Partial college 110 (22.9)  No Religion 69 (14.4)
 College graduates 120 (25.0)  Others 139 (29.0)
 Graduate degree 67 (14.0)
Income Satisfaction US Born
 Totally insufficient 136 (28.3)  Yes 318 (66.3)
 Somewhat insufficient 115 (24.0)  No 162 (33.8)
 Sufficient for essentials 169 (35.2)
 More than sufficient 43 (9.0)
Self-reported Health Status Cancer Treatment
 Very unhealthy 51 (10.6)  Radiation only 16 (3.3)
 Unhealthy 109 (22.7)  Chemotherapy only 77 (16.0)
 Don’t know 66 (13.8)  Surgery only 45 (9.4)
 Healthy 211 (44.0)  Hormone therapy only 2 (0.4)
 Very healthy 41 (8.5)  Combined 325 (67.7)
 Others 15 (3.1)
Cancer Site Cancer Stage
 Breast 217 (45.2)  0 23 (4.8)
 Head & Neck 32 (6.7)  I 79 (16.5)
 Lymph nodes 11 (2.3)  II 122 (25.4)
 Hematologic 14 (2.9)  III 72 (15.0)
 Gastrointestinal 46 (9.6)  IV 61 (12.7)
 Lung 30 (6.3)  Recurrent 24 (5.0)
 Female reproductive organs 39 (8.1)  Not staged 5 (1.0)
 Prostate 10 (2.1)  Unknown 24 (5.0)
 Combined 42 (8.8)
 Others 35 (7.2)
Usage of Pain Medication Regular Access to Health Care
 Yes 179 (37.3)  Yes 450 (93.8)
 No 298 (62.1)  No 29 (6.0)
Place to Seek for Medical Help
 Clinic or Health Center 292 (60.8)
 Hospital Outpatient Dept. 29 (5.8)
 Hospital ER 28 (5.8)
 Others 89 (18.5)

Instruments

Sociodemographic characteristics

Eight questions on age, gender, education, religion, marital status, work, family income, and access to health care were used to measure and describe sociodemographic characteristics of the participants. Self-reported ethnic identity (ethnic group membership) was measured using the ethnic identity question required in the NIH’s reporting guidelines, and there was another question about country of birth.

Self-reported health/illness status

Self-reported health/illness status was measured using one item rating general health, three items about cancer (primary cancer site, stage of cancer, previous medical treatments [e.g., radiation therapy, chemotherapy, surgery and hormone therapy]), and usage of pain medication.

Self-reported cancer pain experiences

In this study, unidimensional (the VDS, the VAS, and the FPS) and multidimensional (the MPQ-SF and the BPI-SF) cancer pain assessment tools were used to measure self-reported cancer pain experience. The reason for using both types of instruments was to increase the validity and reliability of cancer pain measurement through multiple measurements (for confirmation and completeness of data), because very little is known about self-reported cancer pain across ethnic groups.

Verbal Descriptor Scale (VDS)

In this study, a VDS consisting of simple terms including no pain, mild pain, moderate, severe, very severe, and worst possible pain was used to measure self-reported cancer pain. For statistical purposes, the terms were assigned a numerical value from 0 to 5 (0=no pain, 5=worst possible pain). In a study among 71 cancer patients aged 18-85 years with and without pain, the correlation coefficients for test-retest reliability of the VDS was 0.94 (Grossman et al., 1992).

Visual Analog Scale (VAS)

In this study, the VAS consisting of a 10 cm horizontal line with word anchors at each end (i.e., no pain and worst pain possible) included in the McGill Pain Questionnaire-Short Form was used to measure self-reported cancer pain experience. The main advantage of the VAS is that it is relatively easy to complete and score, and it can be useful in measuring pain intensity in relation to treatments. When the VAS was tested with the Face Pain Scale (FS) and the Memorial Pain Assessment Card (MPAC) among multiethnic groups, it was found to be valid and reliable across ethnic groups (Ramer et al., 1999).

Wong-Baker Faces Pain Scale (FS)

In this study, the FS consisting of six faces (Wong & Baker, 1989) was used to measure self-reported cancer pain experience as well: the first picture is a very happy smiling face and the last is a sad, tearful face. The pictures between the two faces indicate varying degrees of sadness. The patient was asked to choose which face is most like his or hers. For statistical purposes, the faces were assigned a numerical value from 0 to 5 (0=a very happy face, 5=a sad, tearful face). Its concurrent validity, construct validity, and test-retest reliability (r = 0.61-0.87) were well established (Herr, Mobily, Kohout, & Wagenaar, 1998).

McGill Pain Questionnaire-short form (MPQ-SF)

In this study, the MPQ-SF by Melzack (1987) was used as a multidimensional pain assessment scale. The MPQ-SF (17 items) has three components: (a) pain rating index (PRI), (b) visual analogue scale (VAS), and (c) present pain intensity (PPI). The PRI consists of 15 descriptors (11 sensory, 4 affective) that are rated on an intensity scale (0=none, 1=mild, 2=moderate, or 3=severe), and the PPI is measured with a 0 to 5 scale of overall pain intensity. In this study, the MPQ-SF pain scores were determined by adding the ratings of all 15 items included in PRI (possible range=0-45). Validity and reliability of the MPQ-SF have been well established among cross-cultural populations (Lazaro, Bosch, Torrubia, & Banos, 1994). Cronbach’s alpha of the MPQ-SF in the study reported in this paper was 0.94.

Brief Pain Inventory-Short Form (BPI-SF)

The BPI-SF (Cleeland, 1985) consists of 15 items that can be categorized into: (a) a global “yes” or “no” item asking for a comparison of pain with other minor aches and pains; (b) four items with 0-10 numerical rating scales for sensory component of pain; (c) an item for pain medications or treatments used; (d) a numerical scale rating the effectiveness of pain relief measures; (e) seven items using 0-10 numerical rating scales for a reactive dimension; and (f) a body diagram to indicate location of pain. In this study, the BPI-SF pain scores were determined by adding the ratings of four items on intensity of pain and seven items on interferences in the patient’s life of pain (possible range=0-110). Validity and reliability of the BPI-SF have been established across cultures and languages (Ger, Ho, Sun, Wang, & Cleeland, 1999). Cronbach’s alpha of the BPI-SF in this study was 0.96.

Symptoms accompanying cancer pain

The MSAS (Portenoy et al., 1994) questions patients about their experiences of 32 symptoms commonly associated with cancer in three dimensions: (a) severity; (b) frequency with which it occurs; and (c) distress it produces. Each symptom is scored from 0 to 4 ranging from “no symptom” to “very much.” Distress is rated on a 5-point (0-4) Likert scale. The MSAS symptom scores were determined by adding the ratings of symptom distress of 32 symptoms (possible range=0-128). The validity and reliability of the MSAS have been established among ethnically diverse populations (Chang, Hwang, Feuerman, Kasimis, & Thaler, 2000). Cronbach’s alpha of the MSAS in the study reported in this paper was 0.93.

Functional status

In this study, functional status was measured using the Functional Assessment of Cancer Therapy Scale (FACT-G), which consists of 33 items with five domains assessing physical well-being, social/family well-being, relationships with the physician, emotional well-being, and functional well-being (Cella et al., 1993). The responses to 28 of the items range from 0 (not at all) to 4 (very much). The five other items, using a linear analogue scale ranging from 0 (not at all) to 10 (very much so), assess the extent to which each domain affects overall quality of life. In this study, the FACT-G scores were determined by adding the ratings of 33 questions (possible range=0-132). Validity and reliability of the FACT-G have been well established among cross-cultural populations (Mullin, 2000; Yu et al., 2000). Cronbach’s alpha of the FACT-G in the study reported in this paper was 0.70.

Data Collection Procedures

To administer the Internet questionnaire, a website conforming to the Health Insurance Portability and Accountability Act (HIPAA) standards, the SANS/Federal Bureau of Investigation (FBI) recommendations, and the IRB policy of the institution where the researchers were affiliated was developed and published on an independent, dedicated website server consisting of 5 Pentium-based computers. When potential participants visited the project website, informed consent was obtained by asking them to click the “I agree to participate” button. Then, questions on specific diagnoses, cancer therapies, and medications were asked, and the appropriateness of their answers was checked automatically through a server-side program; they were automatically connected to the Internet survey web page if the answers were appropriate. When participants were connected to the survey page, they were asked to answer the Internet survey questions.

Upon request by the community consultants, the pen-and-pencil questionnaires were provided by mail to the consultants, who distributed the questionnaires in person only to those who were identified as cancer patients. These questionnaires accompanied hard copies of the same informed consent form that was included in the Internet format of the questionnaire, and the pen-and-pencil questionnaire included a sentence saying “Filling out this questionnaire means that you are aged over 18 years old and giving your consent to participate in this survey.” After self-administering the questionnaires, all completed questionnaires except 5 (that were directly mailed to the research team by the participants) were retrieved by community consultants in person at the community settings and mailed to the research team by the community consultants. Supplementing pen-and-pencil questionnaires was essential to recruit the target number of ethnic minority cancer patients across the nation who did not have access to the Internet but were interested in participating in the study. Among 276 participants who were recruited through community settings, 246 (49 Hispanics, 6 N-H Whites, 99 N-H African Americans, and 92 N-H Asians) used the pen-and-pencil questionnaires. With an alpha level of 0.05, there were no statistically significant differences in psychometric properties (construct validity and Cronbach’s alpha) between the Internet format and the pen-and-pencil format of the questionnaire. More detailed findings on psychometric properties of the Internet and pen-and-pencil formats of the questionnaire can be found elsewhere (Authors, in progress). It took an average of 30-40 minutes for the participants to complete either the Internet format or the pen-and-pencil format of the questionnaire.

Data Analysis Process

The collected data were saved in ASCII format and databases. The data from the Internet survey were automatically and directly saved in the databases as the participants entered the data into the database system. The data from the pen-and-pencil survey were entered by one RA into the database, and two additional RAs double-checked the data entry separately. Then, if one of the RAs found an error, the three RAs together resolved the errors. For both Internet and pen-and-pencil questionnaires, when the missing fields were less than 10%, mean substitution was used to determine the value of missing data. Participants for whom 10% or more data was missing were not included in the analyses. The reason for using 10% tolerance for missing data was because previous research showed that there was little, if any, impact on significance tests or confidence intervals (Little & Rubin, 2002). Although this method might mildly increase the likelihood of type I error, excluding subjects with small amounts of missing data might actually result in a bias toward more healthy, compliant individuals (McLaughlin & Marascuilo, 1990). Then, before conducting data analyses, descriptive statistics were run to check errors or inconsistence in the data, and the data were cleaned while automatically generating the code book.

Socio-demographic profiles, health/illness status, self-reported cancer pain, symptoms accompanying pain, and functional status of the participants were described using descriptive statistics including frequency, percentage, mean, standard deviation, and range. To test hypothesis 1, the data were analyzed using ANOVA. Tukey’s HSD was used to assist in interpreting any significant effects from the ANOVA analysis. Before conducting ANOVA, Levene’s homogeneity test was conducted to determine the homogeneity of the ethnic groups. For the multiple comparisons, a corrected alpha using Bonferroni method was used. Hierarchical stepwise multiple regressions were conducted to determine the effects of ethnicity on cancer pain, symptoms, and functional status while considering other demographic and health/illness factors (Hypothesis 2). For these analyses, demographic factors including age, income satisfaction, and gender were entered first; health/disease factors including cancer stage, health status, and pain medication were entered second; and ethnicity (four dummy codes: being Hispanic or not; being N-H White or not; being N-H African-American or not; and being N-H Asian or not) was entered at last. The increase in R2R2) was computed to determine the relative contributions of each set of variables. Standard coefficients (β) were computed to compare the relative importance of each variable in the model. The data were checked for multicollinearity, using tolerance and the variance inflation factor (VIF). VIF-values greater than 10 and tolerance-values smaller than .10 may indicate multicollinearity. There were no signs of multicollinearity in any of the regression models. All analyses were performed with the SPSS program.

Findings

Self-Reported Cancer Pain, Symptoms, and Functional Status

The ethnic-specific means of the cancer pain, symptoms, and functional status scores are summarized in Table 2. The top five most frequently reported pain descriptors (included in the MPQ scale) according to ethnicity are summarized in Table 3. Aching pain was the most frequently reported pain descriptor among Hispanics and N-H African Americans, and it was the second most frequently reported pain descriptor among N-H Whites and N-H Asians. The most frequently reported pain descriptor among N-H Whites was tiring pain, and that among N-H Asians was tender pain.

Table 2.

A summary of self-reported cancer pain, symptoms, and functional status according to ethnicity.

Cancer Pain Experience Means (SD) SS* df** MS*** F-value P-value
VDS
 Hispanic 1.79 (1.32) Between Groups 46.24 3 15.41 F=8.81 P<0.01*
 N-H White 1.82 (1.40) Within Groups 830.95 475 1.75
 N-H African 1.39 (1.38) Total 877.18 478
 Americans N-H Asian 1.09 (1.16)
VAS
 Hispanic 4.20 (3.20) Between Groups 31679.20 3 10559.73 F=9.98 P<0.01*
 N-H White 4.05 (3.50) Within Groups 443325.23 419 1058.06
 N-H African 2.57 (3.31) Total 475004.43 422
 Americans N-H Asian 2.29 (2.92)
FS
 Hispanic 3.36 (1.49) Between Groups 67.74 3 22.58 F=9.37 p<0.01*
 N-H White 3.34 (1.54) Within Groups 1132.25 270 2.41
 N-H African 2.75 (1.71) Total 1199.99 473
 Americans N-H Asian 2.49 (1.46)
MPQ-SF
 Hispanic 10.86 (1.32) Between Groups 4148.11 3 1382.70 F=14.64 p<0.01*
 N-H White 12.06 Within Groups 42892.81 454 94.48
 N-H African (10.92) Total 47040.92 457
 Americans 6.13 (7.92)
 N-H Asian 5.18 (8.80)
BPI-SF
 Hispanic 42.94 (28.99) Between Groups 17734.71 3 5911.57 F=7.16 p<0.01*
 N-H White 38.85 (28.85) Within Groups 379626.65 460 825.28
 N-H African 32.74 (30.72) Total 397361,36 463
 Americans N-H Asian 26.15 (26.25)
MSAS
 Hispanic 24.45 (22.94) Between Groups 3423.54 3 1141.18 F=2.82 p=.04
 N-H White 20.63 (15.92) Within Groups 192756.96 476 404.95
 N-H African 16.55 (19.40) Total 196180.50 479
 Americans N-H Asian 21.46 (22.77)
FACT-G
 Hispanic 94.76 (20.04) Between Groups 4264.40 3 1421.47 F=4.83 p<0.01*
 N-H White 89.28 (14.91) Within Groups 73824.03 251 294.12
 N-H African Americans 88.84 (18.26) Total 78088.43 254
 N-H Asian 81.15 (17.60)
*

SS=Sum of Squares

**

df=degree of freedom

***

MS=Mean Square

Table 3.

Top 5 most frequently reported pain descriptors included in the MPQ-SF according to ethnicity.

Rank Hispanics N-H Whites N-H African Americans N-H Asians
1 Aching Pain (62%) Tiring Pain (70%) Aching Pain (51%) Tender Pain (35%)
2 Tiring Pain (60%) Aching Pain (69%) Tiring Pain (47%) Aching Pain (29%)
3 Sharp Pain (52%) Throbbing Pain (34%) Sharp Pain (36%) Tiring Pain (26%)
4 Tender Pain (52%) Sharp Pain (36%) Throbbing Pain (34%) Throbbing Pain (25%)
5 Throbbing Pain (46%) Tender Pain (33%) Tender Pain (33%) Cramping and fearful pain (23%)

The top 5 most distressing and bothering symptoms according to ethnicity are summarized in Table 4. The most distressing and bothering symptom among Hispanics and N-H Whites was pain while that among N-H African Americans and Asians was lack of energy. Lack of energy was the second most distressing and bothering symptom among Hispanics and N-H Whites, and pain was the second among N-H African Americans.

Table 4.

Top 5 most distressing and bothering symptoms according to ethnicity.

Rank Hispanics N-H Whites N-H African Americans N-H Asians
1 Pain (67%) Pain (70%) Lack of energy (47%) Lack of energy (55%)
2 Lack of energy (52%) Lack of energy (70%) Pain (44%) Difficulty sleeping (54%)
3 Difficulty sleeping (51%) Difficulty sleeping (61%) Difficulty sleeping (44%) Worrying (50%)
4 Feeling sad (43%) Difficulty concentrating (51%) Numbness/tingling in hands/feet (39%) Pain (49%)
5 Feeling drowsy (39%) Worrying (43%) Worrying (32%) Difficulty concentrating (48%)

Ethnic Differences in Cancer Pain, Symptoms, and Functional Status

There were significant ethnic differences in the VDS score (F=8.81, p<.01), the VAS score (F=9.98, p<.01), the FS score (F=9.37, p<.01), the MPQ score (F=14.64, p<.01), the BPI score (F=7.16, p<.01), and the FACT-G score (F=4.83, p<.01)(Hypothesis 1)(see Table 2). However, there was no significant ethnic difference in the MSAS scores. The post-hoc tests indicated that the VDS, VAS, FS, MPQ, and BPI scores of N-H Asian participants were significantly lower than those of Hispanic and N-H White participants (p<.01). The VAS and MPQ scores of N-H African American participants were significantly lower than those of Hispanic and N-H White participants (p<.01). The FACT-G scores of N-H Asian participants were significantly lower than Hispanic participants (p<.01).

Effects of Ethnicity on Cancer Pain, Symptoms, and Functional Status

Separate hierarchical regression analyses were performed to determine the effects of ethnicity on the main cancer pain, symptom, and functional status scores while controlling for other demographic and health/illness factors (Hypothesis 2) (see Table 5). The overall model fit was still significant once the ethnicity variables were added to the model. With a couple of exceptions, there was a very large F-square change when the cancer stage, health status, and pain medication variables were added to the model. The change in F-square was not as dramatic when the ethnicity variables (being Hispanic or not, being N-H African American or not, and being N-H Asian or not) were present, but there was some indication that the overall model fit was still good (p-values less than .01).

Table 5.

Predictors of cancer pain, symptoms, and functional status: Hierarchical multiple regression

Predictor variables β p-value ΔR2 Fch p-value for Fch
VDS Scores
Step 1 .049 5.979 .001
Age −.055 .236
Income Satisfaction −.021 .656
Gender −.067 .143
Step 2 .277 47.533 .000
Cancer Stage .063 .186
Health Status −.272 .000
Pain Medication −.351 .000
Step 3 .028 4.964 .002
Being Hispanic or Not .002 .962
Being N-H African-American or Not −.072 .139
Being N-H Asian or Not −.186 .000
VAS Scores
Step 1 .054 5.770 .001
Age −.058 .229
Income Satisfaction −.009 .855
Gender −.039 .412
Step 2 .326 52.331 .000
Cancer Stage .092 .063
Health Status −.288 .000
Pain Medication −.367 .000
Step 3 .021 3.447 .017
Being Hispanic or Not .025 .661
Being N-H African-American or Not −.075 .144
Being N-H Asian or Not −.150 .006
FS Scores
Step 1 .048 5.785 .001
Age −.007 .868
Income Satisfaction −.016 .715
Gender −.075 .086
Step 2 .335 62.340 .000
Cancer Stage .070 .129
Health Status −.342 .000
Pain Medication −.354 .000
Step 3 .033 6.439 .000
Being Hispanic or Not .039 .397
Being N-H African-American or Not −.076 .104
Being N-H Asian or Not −.183 .000
MPQ Scores
Step 1 .062 7.401 .000
Age −.073 .111
Income Satisfaction −.001 .979
Gender −.105 .020
Step 2 .275 46.346 .000
Cancer Stage .053 .262
Health Status −.312 .000
Pain Medication −.302 .000
Step 3 .055 10.063 .000
Being Hispanic or Not −.010 .829
Being N-H African-American or Not −.156 .001
Being N-H Asian or Not −.253 .000
BPI Scores
Step 1 .096 12.290 .000
Age −.039 .381
Income Satisfaction −.103 .021
Gender −.077 .074
Step 2 .299 56.814 .000
Cancer Stage .003 .954
Health Status −.346 .000
Pain Medication −.342 .000
Step 3 .031 6.095 .000
Being Hispanic or Not .047 .311
Being N-H African-American or Not −.069 .137
Being N-H Asian or Not −.170 .001
MSAS Scores
Step 1 .094 12.108 .000
Age −.081 .115
Income Satisfaction −.156 .003
Gender −.066 .194
Step 2 .113 16.646 .000
Cancer Stage .064 .224
Health Status −.257 .000
Pain Medication −.164 .002
Step 3 .001 .194 .901
Being Hispanic or Not −.039 .467
Being N-H African-American or Not −.001 .896
Being N-H Asian or Not −.008 .987
FACT-G Scores
Step 1 .063 4.524 .004
Age −.090 .196
Income Satisfaction −.024 .728
Gender −.204 .003
Step 2 .098 7.725 .000
Cancer Stage .208 .004
Health Status −.008 .908
Pain Medication −.165 .024
Step 3 .023 1.863 .137
Being Hispanic or Not .090 .214
Being N-H African-American or Not .066 342
Being N-H Asian or Not −.091 .221
*

ΔR2=R square change

**

Fch=F change

All the variables combined accounted for 35% of the variance in the VDS scores (F=20.92, p<.001). Health status and pain medication were significant predictors of the VDS scores and accounted for 28% of the variance. Being N-H Asian or not was a significant predictor of the VDS scores, and explained about 3% of the variance. A total of 40% of the variance in the VAS scores was explained by all the variables considered (F=22.00, p<.001). Health status and pain medication were significant predictors of the VAS scores and accounted for 33% of the variance. A total of 42% of the variance in the FS scores was explained by the predictor variables (F=27.00, p<.01). Health status and pain medication were significant predictors of the FS scores and accounted for 34% of the variance. Being N-H Asian or not was a significant predictor of the FS scores, and explained about 3% of the variance. All the variables combined accounted for 39% of the variance in the MPQ scores (F=23.80, p<.01). Health status and pain medication were significant predictors of the MPQ scores and accounted for 28% of the variance. All the variables combined also accounted for 43% of the variance in the BPI scores (F=28.16, p<.01). Health status and pain medication were significant predictors of the BPI scores and accounted for 30% of the variance. Being N-H Asian or not was a significant predictor of the BPI scores and accounted for about 3 percent of the variance. A total of 21% of the variance in the MSAS scores was explained by all the variables considered (F=10.117, p<.01). Health status was a significant predictor of the MSAS scores and accounted for 11% of the variance. Finally, a total of 18% of the variance in the FACT-G scores was explained by all the variables considered (F=4.910, p<.01). No significant predictor of the FACT-G scores was identified.

Discussion

The findings of the study reported in this paper strongly support ethnic differences in cancer pain experience. The findings indicated that the cancer pain scores from both unidimensional and multidimensional scales were significantly different according to ethnicity, and being N-H Asian or not was a significant predictor of the VDS, FS, and BPI-SF scores. As indicated in previous studies (Wills & Wootoon, 1999), N-H Asians were the ethnic group who reported the lowest cancer pain scores in all pain scales. The N-H White group reported the highest VDS and MPQ scores while the Hispanic group reported the highest VAS, FS, and BPI scores. The findings on the high VAS, FS, and BPI scores among Hispanics are consistent with previous findings among Hispanic cancer patients (Eversley et al., 2005): Hispanics had the worst pain among multiethnic groups of cancer patients. Yet the finding that N-H African Americans reported lower cancer pain scores than Whites and Hispanics was somewhat different from previous findings among African American cancer patients (Eversley et al., 2005). The possible reason for these findings could be that about 80% of the African American participants of the study reported in this paper were recruited through cancer support groups while about 60% of the Hispanic cancer patients were recruited through cancer clinics.

An interesting finding is that there were no ethnic differences in symptoms accompanying cancer pain and that ethnicity was not a significant predictor of the symptom scores. When considering that Asians reported the lowest cancer pain scores, their symptom scores should be expected to be lower than those of other ethnic groups. However, the findings indicate that there were no significant differences in the MSAS between Asians and other ethnic groups. One possible reason may be that Asians are more hesitant to report pain than they are to report physical and psychological symptoms. In the literature (Lipson & Dibble, 2005), it has been reported that Asians are hesitant to report psychological symptoms such as depression; instead, they report physical symptoms, even when their symptoms are psychological in nature, because psychological symptoms can be stigmatized in Asian cultures. It is possible that Asians do not report pain because it is a signifier of a more serious condition, like cancer, and because pain can be negatively viewed by others (Chung, Wong, & Wang, 2000).

Although very little is known about ethnic differences in the functional status of cancer patients, the finding that Hispanics reported the highest functional status score somewhat agrees with previous findings on family support among Hispanic cancer patients. Functional status has been reported to be influenced by living arrangements and social support (Wan et al., 1999). Compared with other ethnic groups, Hispanic cancer patients tend to be in a better situation in this regard: they were more likely to seek support from family members, friends, and health professionals, to identify a family member as the final treatment decision-maker, and to have strong family support during the diagnosis and treatment process (Maly, Umezawa, Ratliff, & Leake, 2006). Indeed, familialism among Hispanics—strong identity and attachment to the nuclear and extended families as well as loyalty and reciprocity in helping other family members (Maly et al., 2006))— has been frequently reported in the literature. Although Asians and African Americans also have similar cultural values related to their families, they would be different in terms of their behaviors seeking help for their cancer because of the stigmatized nature of cancer (American Cancer Society, 2002; Chung et al., 2000). Subsequently, from this point of view, the findings on the highest functional status scores among Hispanic cancer patients could be understood. However, the finding needs to be carefully interpreted since the hierarchical multiple regression analyses indicated that being Hispanic or not was not a significant predictor of the FACT-G scores despite the finding of significant ethnic differences in the FACT-G scores.

The findings of this study that differed from those of previous studies raised a question about the appropriateness and adequacy of the cancer pain scales, the symptom scale, and the functional status scale for a specific ethnic group of cancer patients. In this study, as reported in the section on the results, Hispanics reported the highest cancer pain scores in the VAS, FS, and BPI-SF while Whites reported the highest scores in the VDS and the MPQ-SF. The finding that a specific ethnic group reported the highest scores in one cancer pain scale but not in another suggests that some scales worked better than other scales in a specific ethnic group. Indeed, recently, some studies have reported this kind of dilemma (Closs & Briggs, 2002). For example, previous studies (Closs & Briggs, 2002) have argued that the MPQ that was developed in Canada may not adequately measure cancer pain even in other English-speaking countries. The variation across the scales is interesting given that each individual scale has high reliability across ethnic groups.

The study reported in this paper has several methodological limitations, one of which is that the participants might not adequately represent ethnic minority cancer patients in the U.S. although a large number of ethnic minority cancer patients were recruited. As described above, we recruited participants through both Internet and community settings to gather equivalent numbers of cancer patients from each of the four ethnic groups. Also, although we designed our multiple recruitment strategies to gather a gender-balanced sample, more women participated than men. As discussed above, this might result from the fact that women outnumber men in the cancer population (American Cancer Society, 2006) and in the Internet population (Fallows, 2005). A third limitation is that there was no control over a child or a family member’s involvement in data collection through the Internet (e.g., a child filling out the survey for the participant) since researchers could not be physically present to witness the activity. However, in the case of the pen-and-pencil questionnaires, all the participants except 5 who returned the questionnaires directly to the research team filled out the questionnaires at community settings while participating in the usual activities (e.g., cancer support groups or treatment modalities), and they returned the questionnaires to the community consultants in person before they left.

Conclusion and Implications

The study reported in this paper indicated certain ethnic differences in types of pain and symptoms that cancer patients experienced. They also reported significant ethnic differences in cancer pain and functional status and indicated that being N-H Asian or not was a significant predictor of several cancer pain scores. Based on the above discussion, this paper concludes with the following suggestions for future research. First, when a specific ethnic group reports the highest cancer pain score in one scale but not another, a question is raised about the appropriateness and adequacy of the scales themselves. Thus, the appropriateness and adequacy of the cancer pain, symptom, and functional status scales need to be further examined in each of the ethnic groups of cancer patients. Second, the findings suggest that cultural values and beliefs that are unique to each ethnic group might have influenced their cancer pain experience. Thus, more in-depth qualitative explorations on cultural values and beliefs related to cancer itself and cancer pain assessment and management process are needed for better cancer pain management. Finally, generalizing study findings needs to be undertaken carefully, given that participants were recruited with a convenience sampling method. National scope studies on ethnic differences in cancer pain experience with an adequate number of ethnic minorities using a systematic recruitment strategy would provide a more comprehensive and generalizable picture of ethnic variations in cancer pain experience.

Supplementary Material

Title page

References

  1. American Cancer Society. Estimated New Cancer Cases and Deaths by Sex for All Sites, US. 2006 Retrieved July, 21, 2006, from http://www.cancer.org/docroot/MED/content/downloads/MED_1_1x_CFF2006_Estimated_New_Cases_Deaths_by_Sex_US.asp.
  2. Anderson, Mendoza, Valero, Richman, Russell, Hurley, et al. Minority cancer patients and their providers. Cancer. 2000;88:1929–1938. [PubMed] [Google Scholar]
  3. Authors. White cancer patients’ perception of gender and ethic differences in pain experience. Cancer Nursing. 2006;29(6):441–50. doi: 10.1097/00002820-200611000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Authors (in progress). Psychometric differences between Internet and pen-and-pencil formats of cancer pain measures.
  5. Cella, Tulsky, Gray, Sarafian, Linn, Bonomi, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11:570–579. doi: 10.1200/JCO.1993.11.3.570. [DOI] [PubMed] [Google Scholar]
  6. Chang, Hwang, Feuerman, Kasimis, Thaler The memorial symptom assessment scale short form (MSAS-SF) Cancer. 2000;89(5):1162–1171. doi: 10.1002/1097-0142(20000901)89:5<1162::aid-cncr26>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  7. Chung, Wong, Wang The lens model: Assessment of cancer pain in a Chinese context. Cancer Nursing. 2000;23(6):454–461. doi: 10.1097/00002820-200012000-00008. [DOI] [PubMed] [Google Scholar]
  8. Cleeland Measurement and prevalence of pain in cancer. Seminars In Oncology Nursing. 1985;1(2):87–92. doi: 10.1016/s0749-2081(85)80041-3. [DOI] [PubMed] [Google Scholar]
  9. Cleeland, Baez, Pandya Pain and treatment of pain in minority patients with cancer. Annals of Internal Medicine. 1997;127(9):813–816. doi: 10.7326/0003-4819-127-9-199711010-00006. [DOI] [PubMed] [Google Scholar]
  10. Cleeland, Gonin, Harfield, Edmonson, Blum, Stewart, et al. Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine. 1994;330:592–596. doi: 10.1056/NEJM199403033300902. [DOI] [PubMed] [Google Scholar]
  11. Closs, &, Briggs Patients’ verbal descriptions of pain and discomfort following orthopaedic surgery. International Journal of Nursing Studies. 2002;39:563–572. doi: 10.1016/s0020-7489(01)00067-0. [DOI] [PubMed] [Google Scholar]
  12. Cohen . Statistical power analysis for the behavioral sciences. 2. Hillsdale, N.J: L. Erlbaum Associates; 1988. [Google Scholar]
  13. Dodd Advancing the science of symptom management. Journal of Advanced Nursing. 2001;33:668–676. doi: 10.1046/j.1365-2648.2001.01697.x. [DOI] [PubMed] [Google Scholar]
  14. Edrington, Paul, Dodd, West, Facione, Tripathy, et al. No evidence for sex differences in the severity and treatment of cancer pain. Journal of Pain & Symptom Management. 2004;28(3):225–232. doi: 10.1016/j.jpainsymman.2003.12.013. [DOI] [PubMed] [Google Scholar]
  15. Eversley, Estrin, Dibble, Wardlaw, Pedrosa, Favila-Penney Post-treatment symptoms among ethnic minority breast cancer survivors. Oncology Nursing Forum. 2005;32(2):250–256. doi: 10.1188/05.ONF.250-256. [DOI] [PubMed] [Google Scholar]
  16. Fallows D. How women and men use the Internet. 2005 from http://www.pewinternet.org.
  17. Ger LP, Ho ST, Sun WZ, Wang MS, Cleeland CS. Validation of the Brief Pain Inventory in a Taiwanese population. Journal of Pain & Symptom Management. 1999;18(5):316–322. doi: 10.1016/s0885-3924(99)00087-1. [DOI] [PubMed] [Google Scholar]
  18. Grossman, Sheidler, McGuire, Geer, Santor, Piantadosi A comparison of the Hopkins Pain Rating Instrument with standard visual analogue and verbal descriptor scales in patients with cancer pain. Journal of Pain & Symptom Management. 1992;7(4):196–203. doi: 10.1016/0885-3924(92)90075-s. [DOI] [PubMed] [Google Scholar]
  19. Hall, &, Stevens Rigor in feminist research. Advances in Nursing Science. 1991;13:16–29. doi: 10.1097/00012272-199103000-00005. [DOI] [PubMed] [Google Scholar]
  20. Herr, Mobily, Kohout, Wagenaar Evaluation of the Faces Pain Scale for use with the elderly. The Clinical Journal Of Pain. 1998;14(1):29–38. doi: 10.1097/00002508-199803000-00005. [DOI] [PubMed] [Google Scholar]
  21. Laliberte . Doctors’ guide to chronic pain: The newest, quickest, and most effective ways to find relief. New York: The Reader’s Digest Association, Inc; 2003. [Google Scholar]
  22. Lazaro, Bosch, Torrubia, Banos The development of a Spanish questionnaire for assessing pain: Preliminary data concerning reliability and validity. European Journal of Psychological Assessment. 1994;10(2):145–151. [Google Scholar]
  23. Lipson, Dibble . Culture and critical care. San Francisco: UCSF Nursing Press; 2005. [Google Scholar]
  24. Little, Rubin . Statistical analysis with missing data. Hobeken, NJ: John Wiley & Sons; 2002. [Google Scholar]
  25. Maly, Umezawa, Ratliff, Leake Racial/ethnic group differences in treatment decision-making and treatment received among older breast carcinoma patients. Cancer. 2006;106(4):957–965. doi: 10.1002/cncr.21680. [DOI] [PubMed] [Google Scholar]
  26. McLaughlin, Marascuilo . Advanced nursing and health care research: Quantification approaches. Philadelphia: W. B. : Saunders; 1990. [Google Scholar]
  27. Melzack The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191–197. doi: 10.1016/0304-3959(87)91074-8. [DOI] [PubMed] [Google Scholar]
  28. Miaskowski Gender differences in pain, fatigue, and depression in patients with cancer. Journal of the National Cancer Institute Monographs. 2004;32:139–143. doi: 10.1093/jncimonographs/lgh024. [DOI] [PubMed] [Google Scholar]
  29. Mullin Development of three African language translations of the FACT-G. Quality of Life Research. 2000;9:139–149. doi: 10.1023/a:1008903304950. [DOI] [PubMed] [Google Scholar]
  30. Murphy KR, Myors B. Statistical power analysis: A simple and gneral model for traditional and modern hypothesis tests. Mahwah, NJ: Lawrence Erlbaum Associates; 2004. [Google Scholar]
  31. Portenoy, Thaler, Kornblith, Lepore, Friedlander-Klar, Kiyasu, et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer. 1994;30A(9):1326–1336. doi: 10.1016/0959-8049(94)90182-1. [DOI] [PubMed] [Google Scholar]
  32. Poulos, Gertz, Pankratz, Post-White Pain, mood disturbance, and quality of life in patients with multiple myeloma. Oncology Nursing Forum. 2001;28:1163–1171. [PubMed] [Google Scholar]
  33. Rabow, &, Dibble Ethnic differences in pain among outpatients with terminal and end-stage chronic illness. Pain Medicine. 2005;6(3):235–241. doi: 10.1111/j.1526-4637.2005.05037.x. [DOI] [PubMed] [Google Scholar]
  34. Ramer, Richardson, Cohen, Bedney, Danley, Judge Multimeasure pain assessment in an ethnically diverse group of patients with cancer. Journal of Transcultural Nursing. 1999;10(2):94–101. doi: 10.1177/104365969901000202. [DOI] [PubMed] [Google Scholar]
  35. Rustøen, Fosså, Skarstein, Moum The impact of demographic and disease-specific variables on pain in cancer patients. Journal of pain and symptom management. 2003;26(2):696–704. doi: 10.1016/s0885-3924(03)00239-2. [DOI] [PubMed] [Google Scholar]
  36. Tabachnick Barbara G, Fidell Linda S. Using Multivariate Statistics. 4. Boston: Allyn and Bacon; 2001. [Google Scholar]
  37. Wan, Counte, Cella, Hernandez, McGuire, Deasay, et al. The impact of socio-cultural factors on health-related quality of life reports among Hispanic and African-American cancer patients. Journal of Outcome Measurement. 1999;3:200–215. [PubMed] [Google Scholar]
  38. Wills, &, Wootoon Concerns and misconceptions about pain among Hong Kong Chinese patients with cancer. Cancer Nursing. 1999;22:408–413. doi: 10.1097/00002820-199912000-00002. [DOI] [PubMed] [Google Scholar]
  39. Wong, &, Baker Pain in children: Comparison of assessment scales. Pediatric Nursing. 1989;14(1):9–17. [PubMed] [Google Scholar]
  40. Yu, Fielding, Chan, Tse, Choi, Lau, et al. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer. 2000;88:1715–1727. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Title page

RESOURCES